Steve Wease

Senior Project Leader

Why I joined Emmes

A fortunate confluence of opportunity and necessity. I needed a change of scenery and was determined to work somewhere where I could put my skills to good use. During my interview I voiced my concern with bias and uncertainty in healthcare decisions and my desire to find truth through solid research. When I was told about the meaning behind Emmes’ name, it seemed like a perfect fit.

How I describe our firm to other people

We plan, manage, analyze, and report results for key research affecting human health. We help to inform healthcare professionals about what is best for their patients.

A bit about me

I have two kids I love spending time with. I’m a big sports fan. My son and I saw Trea Turner hit for the cycle during a Nats-Rockies game, thanks to the Emmes ticket lottery. I love movies and music. I take a day off every January to see as many Oscar nominated films as I can in theatre.

How I chose my career

I wanted to do something to improve public health. I thought clinical trials was my best opportunity to have an impact and make good use of my skill set.

The best part about working here

The people. I love the people I work with; their dedication and engagement in the work that they do, the unselfishness and willingness to do whatever it takes to get the job done right, their friendliness and understanding. I’ve also appreciated being able to do lots of different work and continue lifelong learning.

My background

Born and raised in Baltimore, MD. Prior to joining Emmes I worked at George Washington University on studies of infant anxiety. Prior to that I had stints as a preschool teacher and as a middle school crisis counselor for emotionally disturbed children.


MPH Epidemiology, George Washington University 2004
BS Neuroscience, Brown University 1997

Selected papers and presentations

Phase I/II study of stem-cell transplantation using a single cord blood unit expanded ex vivo with nicotinamide.

A Novel Therapy for Sickle Cell Disease (SCD): Co-Transplantation of Nicord® [Ex Vivo Expanded
Umbilical Cord Blood (UCB) Progenitor Cells with Nicotinamide] and an Unmanipulated
Unrelated UCB Graft Leads to Successful Engraftment and Cure of Severe SCD.

Islet Product Characteristics and Factors Related to Successful Human Islet Transplantation From the Collaborative Islet Transplant Registry(CITR) 1999–2010.

Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality.

HLA Class I Sensitization in Islet Transplant Recipients - Report from the Collaborative Islet Transplant

Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of
autologous cord blood infusion in children with acquired neurologic disorders.

Maternal Panic Disorder: Infant Temperament, Neurophysiology and Parenting Behaviors.

Associated projects

Gamida Cell
Carolinas Cord Blood Bank